CINCINNATI, Aug. 21, 2023 /PRNewswire/ -- Mammotome announced the launch of an innovative new HydroMARK™ Plus Breast Biopsy Site Marker designed to enhance ultrasound visibility, improve ease of ...

"I am excited for this innovative biopsy marker to come to market," said Radiologist Dr. Evita Singh, Director of Breast Imaging at Karmanos Cancer Institute. "After seeing the tabletop test on the ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Market Report for Breast Tissue Markers 2016 - MedCore" report to their offering. The value of the U.S. breast ...

On Friday, the FDA warned against using Hologic Inc.’s HOLX BioZorb Marker products and urged healthcare facilities to return all unused lots. This follows Hologic’s voluntary recall of the BioZorb ...

Hologic is putting down about $310 million to acquire Endomagnetics, the developer of technologies for localizing tumors in breast cancer surgeries without using radioactive materials. Also known as ...

Tissue microarrays application in non-small cell lung carcinoma: Morphometric study of immunohistochemical expression of topoisomerase IIa correlating with molecular detection of the specific gene ...

A new study has discovered that 'crown-like structures' surrounding breast tumors in overweight and obese patients could hinder their response to therapy. The findings of this study could potentially ...

Breast cancer remains one of the most prevalent and deadly forms of cancer among women worldwide. Early detection is crucial, as it significantly enhances the chances of successful treatment and ...

The ratio of cyclin D1/p21kip baseline gene expression and SPARC gene expression can be potential predictors of non-Hodgkin's lymphoma (NHL) patient response to lenalidomide therapy No significant ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...